Yee Wah Chin, Counsel, Ingram Yuzek Gainen Carroll & Bertolotti, LLP

#189 What’s at Stake Here? Issues With the State Antitrust Enforcement Venue Act

Posted 4 years ago Tagged

Compared to other proposals to reform the U.S. antitrust regime, the State Antitrust Enforcement Venue […]

H Stephen Harris Jr., Attorney at Law

#187 What Has Changed (or Not) in 14 Years? Conversation With Steve Harris on the Development of China’s Anti-Monopoly Law

Posted 4 years ago Tagged

The Anti-Monopoly Law (AML) is China’s principal antitrust statute, as recently amended in August 2022, […]

Isabel Tecu, Principal, Charles River Associates

#179 What Have We Learned From Empirical Studies? Potential Antitrust Concerns Arising From Common Ownership

Posted 4 years ago Tagged

There is a growing interest in understanding the “ownership interests hypothesis,” i.e., whether investors holding […]

Biologically Similar but Competitively Not So? Economic Considerations of IP Litigation Settlements Involving Biosimilars

#172 Biologically Similar but Competitively Not So? Economic Considerations of IP Litigation Settlements Involving Biosimilars

Posted 4 years ago Tagged

Under the U.S. Supreme Court case FTC v. Actavis (2013), antitrust analysis of “reverse settlements” […]